Estados financieros detallados de Fractyl Health, Inc. (GUTS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.56, GUTS presenta beneficios negativos (P/E no significativo) y un ROE del -16.26%. La capitalización bursátil es de $89M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | $120000 | $93000 | 0 |
| Coste de Ventas | $893000 | $770000 | 0 | $452000 | $77000 | $50000 | 0 |
| Beneficio Bruto | -$893000 | -$770000 | 0 | -$452000 | $43000 | $43000 | 0 |
| I+D | $20.9M | $22.4M | $26.4M | $34.4M | $38.0M | $70.5M | $74.5M |
| Generales y Administrativos | $8.1M | $5.8M | $10.5M | $14.6M | 0 | 0 | $22.3M |
| Gastos Operativos | $29.0M | $28.2M | $36.9M | $48.9M | $50.9M | $93.6M | $96.8M |
| Beneficio Operativo | -$29.9M | -$29.0M | -$36.9M | -$49.4M | -$50.8M | -$93.5M | -$96.8M |
| EBITDA | -$29.0M | -$28.2M | -$36.6M | -$46.0M | -$76.8M | -$68.0M | -$139.8M |
| Gastos por Intereses | $635000 | $1.5M | $1.4M | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$30.6M | -$30.5M | -$38.7M | -$46.5M | -$77.1M | -$68.7M | -$141.0M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$30.6M | -$30.5M | -$38.7M | -$46.5M | -$77.1M | -$68.7M | -$141.0M |
| BPA | $-0.64 | $-0.86 | $-1.12 | $-1.34 | $-1.98 | $-1.62 | $-0.92 |
| BPA Diluido | $-0.64 | $-0.86 | $-1.12 | $-1.34 | $-1.98 | $-1.62 | $-0.92 |
| Acciones en Circulación (Diluidas) | $47.6M | $47.6M | $47.6M | $47.6M | $47.6M | $43.5M | $153.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$22.7M | -$23.3M | -$20.8M | -$19.1M |
| EBITDA | -$45.3M | -$43.4M | $9.5M | -$25.0M |
| Beneficio Neto | -$45.6M | -$43.7M | $9.2M | -$25.5M |
| BPA | $-0.71 | $-0.29 | $0.06 | $-0.16 |
| BPA Diluido | $-0.71 | $-0.29 | $0.06 | $-0.16 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $5.8M | $29.1M | $95.5M | $49.3M | $33.5M | $67.5M | $81.5M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | $22000 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | $73000 | $73000 | 0 |
| Activos Corrientes | $6.8M | $30.9M | $96.4M | $51.6M | $35.6M | $71.8M | $87.6M |
| Inmovilizado Material | $2.1M | $1.4M | $1.3M | $1.6M | $30.8M | $31.4M | $29.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $863000 | $835000 | 0 | 0 |
| Activos Totales | $8.9M | $34.8M | $102.5M | $61.0M | $76.2M | $108.1M | $121.4M |
| Cuentas por Pagar | $608000 | $304000 | $970000 | $980000 | $553000 | $3.2M | $1.6M |
| Deuda a Corto | 0 | $7.2M | $15.7M | 0 | $2.7M | 0 | $5.1M |
| Pasivos Corrientes | $3.4M | $10.9M | $23.7M | $7.3M | $11.2M | $19.8M | $18.3M |
| Deuda a Largo | $14.9M | $8.1M | $287.3M | $305.1M | $342.5M | $30.2M | $30.6M |
| Pasivos Totales | $152.9M | $19.8M | $311.9M | $313.3M | $401.3M | $79.7M | $111.9M |
| Reservas | -$153.9M | -$184.3M | -$223.1M | -$269.5M | -$346.6M | -$415.3M | -$556.3M |
| Patrimonio Neto | -$144.0M | $15.0M | -$209.3M | -$252.3M | -$325.1M | $28.4M | $9.5M |
| Deuda Total | $14.9M | $15.3M | $304.3M | $306.8M | $373.7M | $62.5M | $61.6M |
| Deuda Neta | $9.1M | -$13.8M | $208.9M | $257.5M | $340.2M | -$5.0M | -$19.9M |
| Capital Circulante | $3.4M | $20.0M | $72.7M | $44.3M | $24.5M | $52.0M | $69.2M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $77.7M | $81.5M | $63.2M | $47.1M |
| Activos Totales | $114.3M | $121.4M | $99.4M | $82.0M |
| Pasivos Totales | $117.5M | $111.9M | $78.0M | $83.6M |
| Patrimonio Neto | -$3.2M | $9.5M | $21.4M | -$1.7M |
| Deuda Total | $62.2M | $61.6M | $60.8M | $60.7M |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$30.6M | -$30.5M | -$38.7M | -$46.5M | -$77.1M | -$68.7M | -$141.0M |
| Amortizaciones | $893000 | $770000 | $676000 | $452000 | $286000 | $677000 | $1.1M |
| Compensación en Acciones | $2.5M | $1.6M | $2.1M | $3.1M | $4.3M | $14.4M | $6.7M |
| Cambio en Capital Circulante | -$824000 | -$3.5M | $1.7M | -$1.2M | $989000 | $9.6M | -$395000 |
| Flujo de Caja Operativo | -$27.7M | -$31.1M | -$33.5M | -$46.2M | -$42.8M | -$65.5M | -$90.3M |
| Inversiones (CapEx) | -$97000 | -$2000 | -$51000 | -$56000 | -$359000 | -$1.8M | -$557000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$27.8M | -$31.1M | -$33.5M | -$46.3M | -$43.2M | -$67.3M | -$90.9M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$22.7M | -$21.3M | -$22.5M | -$15.9M |
| Inversiones (CapEx) | -$8000 | -$3000 | 0 | 0 |
| Flujo de Caja Libre | -$22.7M | -$21.3M | -$22.5M | -$15.9M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.6M | $1.9M | $2.5M | $2.5M |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | | | -22.5% | -100.0% |
| Crecimiento Beneficio Neto (anual) | | +0.4% | -27.1% | -19.9% | -66.0% | +10.9% | -105.2% |
| Crecimiento BPA (anual) | | -34.4% | -30.2% | -19.6% | -47.8% | +18.2% | +43.2% |
| Cambio en Acciones (anual) | | +0.0% | +0.0% | +0.0% | +0.0% | -8.5% | +252.2% |
| Crecimiento FCF (anual) | | -11.7% | -7.8% | -38.2% | +6.7% | -55.8% | -35.1% |
| Margen Bruto | | | | | 35.8% | 46.2% | |
| Margen Operativo | | | | | -42363.3% | -100571.0% | |
| Margen EBITDA | | | | | -64004.2% | -73136.6% | |
| Margen Neto | | | | | -64242.5% | -73864.5% | |
| Margen FCF | | | | | -35985.0% | -72350.5% | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.58 | $-0.65 | $-0.70 | $-0.97 | $-0.91 | $-1.55 | $-0.59 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $47.6M | $47.6M | $47.6M | $47.6M | $47.6M | $43.5M | $153.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -1625.88% |
| Rentabilidad sobre capital invertido | -120.27% |
| Rentabilidad sobre activos | -128.88% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | -36.48 |
| Ratio corriente | 3.15 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -7.47 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -20.08 | -14.94 | -11.47 | -9.59 | -6.49 | -1.27 | -2.39 |
| P/VC | -4.25 | 40.92 | -2.92 | -2.42 | -1.88 | 3.16 | 35.68 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 5097.94 | 964.47 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 35.8% | 46.2% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | -42363.3% | -100571.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | -64242.5% | -73864.5% | 0.0% |